May 27, 2014
BioMarin Doses First Patient in Phase 3 INSPIRE Trial with BMN 701 for the Treatment of Pompe
San Rafael, Calif., May 27, 2014 – BioMarin Pharmaceutical Inc. announced today that it has dosed the first patient with
Update: May 4, 2014 THE AMDA TO CELEBRATE THE FIRST INTERNATIONAL POMPE DAY WITH COMMEMORATIVE BOOK April 15, 2014 marked
February 27, 2014
The Contribution Of The IPA Survey To Our Understanding Of The Natural Course Of Pompe Disease
Webinar Details Title: The contribution of the IPA survey to our understanding of the natural course of Pompe disease and
February 23, 2014
2014 AMDA Pull for Pompe
On Saturday April 5, 2014 the AMDA will host the Fourth Annual Pull for Pompe at the National Shooting Complex
February 11, 2014
Update on Genzyme’s neo-GAA Pompe Clinical Development Program
To read the Program Update, please click here.